| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11014879 | The Journal of Heart and Lung Transplantation | 2018 | 7 Pages |
Abstract
We have demonstrated the feasibility of utilizing HCV Ab+/NAT- donors for cardiac transplantation without recipient infection. A small percentage of recipients developed HCV Ab without evidence of viremia, possibly consistent with a biological false reactive test, as has been seen in other settings. Large-scale validation of our data may have a significant impact on transplantation rates.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Snehal R. MD, Shivank MD, Omar MD, Daniel B. MD, J. Julia MD, Cecilia RN, Edward BA, Doctor Y. MD, William MD, Stephen MD, Sasa MD, Sandhya MD, John MD, Yoram MD, Daniel J. MD, Ulrich P. MD,